nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—GABRB2—hindbrain—Parkinson's disease	0.0139	0.0463	CbGeAlD
Alprazolam—GABRA2—hindbrain—Parkinson's disease	0.0127	0.0423	CbGeAlD
Alprazolam—GABRA1—hindbrain—Parkinson's disease	0.0122	0.0409	CbGeAlD
Alprazolam—GABRA5—forebrain—Parkinson's disease	0.0101	0.0338	CbGeAlD
Alprazolam—GABRB2—brainstem—Parkinson's disease	0.00795	0.0266	CbGeAlD
Alprazolam—GABRB2—forebrain—Parkinson's disease	0.00767	0.0256	CbGeAlD
Alprazolam—GABRG2—forebrain—Parkinson's disease	0.00767	0.0256	CbGeAlD
Alprazolam—GABRA2—brainstem—Parkinson's disease	0.00726	0.0243	CbGeAlD
Alprazolam—GABRA1—brainstem—Parkinson's disease	0.00702	0.0234	CbGeAlD
Alprazolam—GABRA2—forebrain—Parkinson's disease	0.00701	0.0234	CbGeAlD
Alprazolam—GABRA1—forebrain—Parkinson's disease	0.00678	0.0226	CbGeAlD
Alprazolam—GABRB3—forebrain—Parkinson's disease	0.00589	0.0197	CbGeAlD
Alprazolam—GABRA5—head—Parkinson's disease	0.00579	0.0193	CbGeAlD
Alprazolam—GABRG2—medulla oblongata—Parkinson's disease	0.00554	0.0185	CbGeAlD
Alprazolam—GABRB2—medulla oblongata—Parkinson's disease	0.00554	0.0185	CbGeAlD
Alprazolam—GABRA5—nervous system—Parkinson's disease	0.00549	0.0183	CbGeAlD
Alprazolam—GABRA3—head—Parkinson's disease	0.00539	0.018	CbGeAlD
Alprazolam—GABRA5—central nervous system—Parkinson's disease	0.00528	0.0177	CbGeAlD
Alprazolam—GABRA3—nervous system—Parkinson's disease	0.00511	0.0171	CbGeAlD
Alprazolam—GABRB2—midbrain—Parkinson's disease	0.00507	0.0169	CbGeAlD
Alprazolam—GABRG2—midbrain—Parkinson's disease	0.00507	0.0169	CbGeAlD
Alprazolam—GABRB2—spinal cord—Parkinson's disease	0.00494	0.0165	CbGeAlD
Alprazolam—GABRG2—spinal cord—Parkinson's disease	0.00494	0.0165	CbGeAlD
Alprazolam—GABRA3—central nervous system—Parkinson's disease	0.00492	0.0164	CbGeAlD
Alprazolam—GABRA1—medulla oblongata—Parkinson's disease	0.00489	0.0164	CbGeAlD
Alprazolam—GABRA1—midbrain—Parkinson's disease	0.00447	0.0149	CbGeAlD
Alprazolam—GABRB2—head—Parkinson's disease	0.00439	0.0147	CbGeAlD
Alprazolam—GABRG2—head—Parkinson's disease	0.00439	0.0147	CbGeAlD
Alprazolam—GABRA1—spinal cord—Parkinson's disease	0.00436	0.0146	CbGeAlD
Alprazolam—GABRB3—medulla oblongata—Parkinson's disease	0.00426	0.0142	CbGeAlD
Alprazolam—GABRA5—brain—Parkinson's disease	0.0042	0.014	CbGeAlD
Alprazolam—GABRB2—nervous system—Parkinson's disease	0.00417	0.0139	CbGeAlD
Alprazolam—GABRG2—nervous system—Parkinson's disease	0.00417	0.0139	CbGeAlD
Alprazolam—GABRA2—head—Parkinson's disease	0.00401	0.0134	CbGeAlD
Alprazolam—GABRB2—central nervous system—Parkinson's disease	0.00401	0.0134	CbGeAlD
Alprazolam—GABRG2—central nervous system—Parkinson's disease	0.00401	0.0134	CbGeAlD
Alprazolam—GABRB2—cerebellum—Parkinson's disease	0.00392	0.0131	CbGeAlD
Alprazolam—GABRG2—cerebellum—Parkinson's disease	0.00392	0.0131	CbGeAlD
Alprazolam—GABRA3—brain—Parkinson's disease	0.00391	0.013	CbGeAlD
Alprazolam—GABRB3—midbrain—Parkinson's disease	0.00389	0.013	CbGeAlD
Alprazolam—GABRA1—head—Parkinson's disease	0.00388	0.013	CbGeAlD
Alprazolam—GABRA2—nervous system—Parkinson's disease	0.00381	0.0127	CbGeAlD
Alprazolam—GABRB3—spinal cord—Parkinson's disease	0.0038	0.0127	CbGeAlD
Alprazolam—GABRA1—nervous system—Parkinson's disease	0.00368	0.0123	CbGeAlD
Alprazolam—GABRA2—central nervous system—Parkinson's disease	0.00366	0.0122	CbGeAlD
Alprazolam—GABRA2—cerebellum—Parkinson's disease	0.00358	0.012	CbGeAlD
Alprazolam—GABRA1—central nervous system—Parkinson's disease	0.00354	0.0118	CbGeAlD
Alprazolam—GABRA1—cerebellum—Parkinson's disease	0.00346	0.0116	CbGeAlD
Alprazolam—GABRB3—head—Parkinson's disease	0.00337	0.0113	CbGeAlD
Alprazolam—CYP2C9—cardiovascular system—Parkinson's disease	0.00334	0.0112	CbGeAlD
Alprazolam—GABRB3—nervous system—Parkinson's disease	0.0032	0.0107	CbGeAlD
Alprazolam—GABRB2—brain—Parkinson's disease	0.00318	0.0106	CbGeAlD
Alprazolam—GABRG2—brain—Parkinson's disease	0.00318	0.0106	CbGeAlD
Alprazolam—GABRB3—central nervous system—Parkinson's disease	0.00308	0.0103	CbGeAlD
Alprazolam—GABRB3—cerebellum—Parkinson's disease	0.00301	0.0101	CbGeAlD
Alprazolam—GABRA2—brain—Parkinson's disease	0.00291	0.00972	CbGeAlD
Alprazolam—GABRA1—brain—Parkinson's disease	0.00281	0.00939	CbGeAlD
Alprazolam—GABRB3—brain—Parkinson's disease	0.00245	0.00817	CbGeAlD
Alprazolam—Clonazepam—CYP2E1—Parkinson's disease	0.00218	0.0776	CrCbGaD
Alprazolam—Loxapine—HTR7—Parkinson's disease	0.0021	0.0746	CrCbGaD
Alprazolam—Loxapine—DRD3—Parkinson's disease	0.00197	0.0701	CrCbGaD
Alprazolam—Loxapine—DRD1—Parkinson's disease	0.00194	0.0688	CrCbGaD
Alprazolam—Loxapine—SLC6A3—Parkinson's disease	0.00184	0.0652	CrCbGaD
Alprazolam—Flunitrazepam—CYP2E1—Parkinson's disease	0.00175	0.0623	CrCbGaD
Alprazolam—Chlordiazepoxide—CYP2D6—Parkinson's disease	0.00166	0.059	CrCbGaD
Alprazolam—CYP3A4—nervous system—Parkinson's disease	0.00164	0.00547	CbGeAlD
Alprazolam—Loxapine—HTR1A—Parkinson's disease	0.00161	0.0572	CrCbGaD
Alprazolam—Nitrazepam—CYP2E1—Parkinson's disease	0.00158	0.0562	CrCbGaD
Alprazolam—CYP3A4—central nervous system—Parkinson's disease	0.00158	0.00527	CbGeAlD
Alprazolam—Ketazolam—ABCB1—Parkinson's disease	0.00142	0.0505	CrCbGaD
Alprazolam—Flurazepam—CYP2E1—Parkinson's disease	0.00141	0.05	CrCbGaD
Alprazolam—Loxapine—DRD2—Parkinson's disease	0.00137	0.0485	CrCbGaD
Alprazolam—Midazolam—CYP2E1—Parkinson's disease	0.00131	0.0463	CrCbGaD
Alprazolam—Diazepam—CYP2E1—Parkinson's disease	0.00112	0.0397	CrCbGaD
Alprazolam—Loxapine—HTR2A—Parkinson's disease	0.00106	0.0375	CrCbGaD
Alprazolam—Clobazam—ABCB1—Parkinson's disease	0.001	0.0357	CrCbGaD
Alprazolam—Nitrazepam—ABCB1—Parkinson's disease	0.00083	0.0295	CrCbGaD
Alprazolam—Flurazepam—ABCB1—Parkinson's disease	0.000738	0.0262	CrCbGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000726	0.00108	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	0.000723	0.00108	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	0.000718	0.00107	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000716	0.00106	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000715	0.00106	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	0.000713	0.00106	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.00071	0.00106	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000705	0.00105	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—COMT—Parkinson's disease	0.000705	0.00105	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000704	0.00105	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—GSTP1—Parkinson's disease	0.000701	0.00104	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.0007	0.00104	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—MAOA—Parkinson's disease	0.0007	0.00104	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—COMT—Parkinson's disease	0.000695	0.00103	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000692	0.00103	CbGpPWpGaD
Alprazolam—Midazolam—ABCB1—Parkinson's disease	0.000684	0.0243	CrCbGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000679	0.00101	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000677	0.00101	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000674	0.001	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP2D6—Parkinson's disease	0.000672	0.000999	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000671	0.000998	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000671	0.000997	CbGpPWpGaD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000664	0.000987	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000663	0.000986	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000655	0.000974	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000651	0.000968	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000646	0.000961	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—GSTM1—Parkinson's disease	0.000644	0.000958	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000637	0.000948	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000636	0.000945	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000635	0.000945	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—COMT—Parkinson's disease	0.000632	0.00094	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000628	0.000934	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000628	0.000933	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000621	0.000923	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000621	0.000923	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000617	0.000917	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—CYP2E1—Parkinson's disease	0.000615	0.000914	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000612	0.00091	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—COMT—Parkinson's disease	0.00061	0.000908	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00061	0.000907	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—COMT—Parkinson's disease	0.000606	0.000902	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000606	0.000902	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.000606	0.000901	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.000602	0.000895	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000599	0.00089	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—COMT—Parkinson's disease	0.000595	0.000885	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000591	0.000879	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000588	0.000875	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000588	0.000875	CbGpPWpGaD
Alprazolam—Diazepam—ABCB1—Parkinson's disease	0.000586	0.0208	CrCbGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000585	0.000869	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000578	0.000859	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000574	0.000854	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000561	0.000835	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000551	0.000819	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000542	0.000805	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000538	0.0008	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000538	0.0008	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000528	0.000786	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—COMT—Parkinson's disease	0.00052	0.000774	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000517	0.000768	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—COMT—Parkinson's disease	0.000509	0.000757	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTP1—Parkinson's disease	0.000507	0.000754	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.000506	0.000752	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.000502	0.000747	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000502	0.000746	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.0005	0.000743	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000493	0.000732	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000474	0.000705	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000472	0.000701	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000467	0.000695	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.000466	0.000693	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000465	0.000692	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000462	0.000687	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000459	0.000683	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ND3—Parkinson's disease	0.000457	0.000679	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MCCC1—Parkinson's disease	0.000457	0.000679	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000453	0.000673	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000443	0.000658	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000433	0.000644	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—OMD—Parkinson's disease	0.00043	0.000639	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TALDO1—Parkinson's disease	0.00043	0.000639	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000427	0.000636	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00042	0.000625	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000412	0.000612	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NDUFB11—Parkinson's disease	0.000407	0.000606	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.0004	0.000595	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000397	0.000591	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000397	0.00059	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000396	0.000589	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000395	0.000588	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000393	0.000584	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GCH1—Parkinson's disease	0.000389	0.000578	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000386	0.000574	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000384	0.000571	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000383	0.00057	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000377	0.000561	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000376	0.00056	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00037	0.000551	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000368	0.000547	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000361	0.000537	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000359	0.000534	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000357	0.000531	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000357	0.00053	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000354	0.000527	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000352	0.000524	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GBA—Parkinson's disease	0.000346	0.000515	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—DBH—Parkinson's disease	0.000346	0.000515	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—FBP1—Parkinson's disease	0.000346	0.000515	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000344	0.000511	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000334	0.000496	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.00033	0.000491	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ND3—Parkinson's disease	0.00033	0.000491	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00033	0.00049	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000329	0.000489	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000328	0.000488	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000328	0.000487	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000324	0.000482	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000322	0.000479	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00032	0.000476	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00032	0.000476	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000316	0.00047	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000315	0.000468	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000314	0.000467	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000312	0.000465	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000311	0.000462	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000311	0.000462	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000309	0.00046	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000308	0.000458	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000307	0.000457	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000302	0.000448	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.000294	0.000438	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000288	0.000429	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000286	0.000425	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000282	0.000419	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GCH1—Parkinson's disease	0.000281	0.000418	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000275	0.000408	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000264	0.000392	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—DDC—Parkinson's disease	0.000254	0.000378	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—FBP1—Parkinson's disease	0.00025	0.000372	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GBA—Parkinson's disease	0.00025	0.000372	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—DBH—Parkinson's disease	0.00025	0.000372	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000247	0.000368	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTA4—Parkinson's disease	0.00024	0.000357	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000237	0.000352	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000236	0.00035	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000235	0.00035	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000234	0.000347	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000233	0.000346	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000233	0.000346	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000233	0.000346	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000232	0.000346	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000219	0.000326	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000219	0.000326	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000217	0.000322	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	0.000216	0.000321	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MAOB—Parkinson's disease	0.000214	0.000318	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000214	0.000318	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000208	0.000309	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000198	0.000294	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—DDC—Parkinson's disease	0.000184	0.000273	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000179	0.000266	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000176	0.000262	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000176	0.000262	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000176	0.000262	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA4—Parkinson's disease	0.000174	0.000258	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	0.000159	0.000236	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	0.000156	0.000232	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CTGF—Parkinson's disease	0.000156	0.000232	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MAOB—Parkinson's disease	0.000155	0.00023	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000154	0.000228	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000154	0.000228	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	0.000145	0.000216	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000144	0.000215	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000144	0.000215	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NQO1—Parkinson's disease	0.000144	0.000214	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TH—Parkinson's disease	0.000142	0.000211	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000137	0.000204	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYCS—Parkinson's disease	0.000136	0.000202	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000131	0.000194	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—DDC—Parkinson's disease	0.00013	0.000193	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000122	0.000182	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000121	0.00018	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—COMT—Parkinson's disease	0.000121	0.000179	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—Parkinson's disease	0.00012	0.000178	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MAOA—Parkinson's disease	0.00012	0.000178	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMOX1—Parkinson's disease	0.000118	0.000176	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000116	0.000173	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000116	0.000173	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000116	0.000173	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	0.000115	0.000171	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCB1—Parkinson's disease	0.000114	0.000169	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CTGF—Parkinson's disease	0.000113	0.000168	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—Parkinson's disease	0.00011	0.000164	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.00011	0.000164	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000109	0.000162	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GPX1—Parkinson's disease	0.000106	0.000157	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	0.000105	0.000156	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NQO1—Parkinson's disease	0.000104	0.000155	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000104	0.000154	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TH—Parkinson's disease	0.000102	0.000152	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYCS—Parkinson's disease	9.84e-05	0.000146	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTHFR—Parkinson's disease	9.74e-05	0.000145	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOE—Parkinson's disease	9.07e-05	0.000135	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—COMT—Parkinson's disease	8.71e-05	0.00013	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—Parkinson's disease	8.67e-05	0.000129	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MAOA—Parkinson's disease	8.65e-05	0.000129	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMOX1—Parkinson's disease	8.55e-05	0.000127	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—DDC—Parkinson's disease	8.54e-05	0.000127	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCB1—Parkinson's disease	8.21e-05	0.000122	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	8.1e-05	0.00012	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	8.07e-05	0.00012	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—Parkinson's disease	7.97e-05	0.000118	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CTGF—Parkinson's disease	7.95e-05	0.000118	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—INS—Parkinson's disease	7.75e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GPX1—Parkinson's disease	7.63e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	7.41e-05	0.00011	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NQO1—Parkinson's disease	7.33e-05	0.000109	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	7.26e-05	0.000108	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TH—Parkinson's disease	7.22e-05	0.000107	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MAOB—Parkinson's disease	7.19e-05	0.000107	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTHFR—Parkinson's disease	7.04e-05	0.000105	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYCS—Parkinson's disease	6.93e-05	0.000103	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOE—Parkinson's disease	6.55e-05	9.75e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—COMT—Parkinson's disease	6.14e-05	9.13e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—Parkinson's disease	6.11e-05	9.09e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MAOA—Parkinson's disease	6.1e-05	9.07e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMOX1—Parkinson's disease	6.03e-05	8.96e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCB1—Parkinson's disease	5.78e-05	8.6e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—Parkinson's disease	5.62e-05	8.35e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—INS—Parkinson's disease	5.6e-05	8.33e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GPX1—Parkinson's disease	5.38e-05	8e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.34e-05	7.95e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.24e-05	7.8e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTHFR—Parkinson's disease	4.96e-05	7.38e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.89e-05	7.27e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.83e-05	7.19e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TH—Parkinson's disease	4.76e-05	7.08e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOE—Parkinson's disease	4.62e-05	6.87e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.57e-05	6.8e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—COMT—Parkinson's disease	4.05e-05	6.02e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.03e-05	5.99e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.02e-05	5.98e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.97e-05	5.91e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—INS—Parkinson's disease	3.95e-05	5.87e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.82e-05	5.67e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.7e-05	5.51e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.55e-05	5.27e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.27e-05	4.87e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOE—Parkinson's disease	3.05e-05	4.53e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—INS—Parkinson's disease	2.6e-05	3.87e-05	CbGpPWpGaD
